about
In vivo selection of protease cleavage sites by using chimeric Sindbis virus librariesIncreased differentiation of dermal mast cells in mice lacking the Mpl gene.Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines.Globin chain synthesis in single erythroid bursts from cord blood: studies on gamma leads to beta and G gamma leads to A gamma switches.GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant.Removal of the spleen in mice alters the cytokine expression profile of the marrow micro-environment and increases bone formation.Thrombopoietin inhibits murine mast cell differentiation.Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutationInterleukin-3 and erythropoietin cooperate in the regulation of the expression of erythroid-specific transcription factors during erythroid differentiation.Development of humanized mice for the study of hepatitis C virus infection.Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides.Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program.Early fluctuations of BFU-E pool size after transfusion or erythropoietin treatment.Testosterone action on BFU-E and CFU-E: correlation between enhancement of proliferative rate and amplification of pool size.The EMA Framework of Collaboration With Academic Stakeholders.Long-term storage does not alter functionality of in vitro generated human erythroblasts: implications for ex vivo generated erythroid transfusion products.In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients.Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase.Erythroid stem cell kinetics: experimental and clinical aspects.Cord blood stem cell banking: a snapshot of the Italian situation.The early stage of friend virus erythroleukemias: a tentative model.Challenges with advanced therapy medicinal products and how to meet them.Fluctuations of BFUe and CFUe cycling after erytrhoid perturbations: correlation with variations of pool size.Umbilical cord blood cells: informed consentCell-based treatments: advanced therapies and transplantsRole of the EU Framework in Regulation of Stem Cell-Based Products
P50
Q27469601-1ECE9E9F-B08F-444D-BB67-E1DDDE9CFE1CQ35101887-C2EFB102-AC69-49CE-90C8-CA83185F12F1Q35891531-2BE857B5-FDAE-4D5F-B8B2-E0D07124D7DEQ36352080-BFDD818A-0478-447E-B452-ED385715833AQ36370557-4A819C8F-48D9-4859-9C1F-8DDA14E1F7DDQ36949506-92D1ABEC-BCA5-43E7-B8F4-5C80E82B2A03Q37341901-29040359-A307-49C3-929C-F394C6DAA72EQ37348257-97628B89-6F15-481F-B07A-F7171D99D52BQ40118006-E0681F33-39EF-4EF4-B5FD-ADCA6BB2C790Q40270960-76EB4579-5EFD-4E10-8245-CFF17E846FACQ40604363-6B143F6C-CB19-4220-A57C-FF4366C3A944Q41055865-6B32E776-573F-4839-A7C8-0EBE53DB0015Q41492176-D1C45152-1E16-41D8-B79E-695EEF1BAE0CQ41642410-2F3FD02F-38E4-4C09-99F0-3FD963969BE4Q42859451-D09D3E34-8721-40EC-8EC9-333BCFA09FA9Q43297696-9445D7B2-9664-4384-BACB-82023C5EC652Q44028088-900E6416-C49D-43C5-95AF-4D3FDE78E4D2Q44738634-999D2573-EDA0-44F6-B45D-D74E3FF6BF60Q44995385-0AAC0465-0E57-4987-924B-53F0844A1D8CQ45332228-EEB2BF7F-6387-423C-B299-A58837A98E51Q45792371-7D23BC06-0091-4A42-9594-69AB8E3D2292Q45857265-7F7948BC-09DD-4B3D-BF71-F65EF4DD9C5FQ47299516-3F347F42-0E0A-4582-AB44-3D6DBEA304D3Q71859012-615597EA-7DAA-438B-B8CB-29D361209669Q83446967-77AE6D4D-157F-42F5-B4A6-DCDAA4EFD7F1Q84655013-1ED19BE8-22FB-4271-8CEF-EB4164B6FC68
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanni Migliaccio
@ast
Giovanni Migliaccio
@en
Giovanni Migliaccio
@es
Giovanni Migliaccio
@nl
Giovanni Migliaccio
@sl
type
label
Giovanni Migliaccio
@ast
Giovanni Migliaccio
@en
Giovanni Migliaccio
@es
Giovanni Migliaccio
@nl
Giovanni Migliaccio
@sl
prefLabel
Giovanni Migliaccio
@ast
Giovanni Migliaccio
@en
Giovanni Migliaccio
@es
Giovanni Migliaccio
@nl
Giovanni Migliaccio
@sl
P106
P21
P31
P496
0000-0001-8951-9957